Pregled bibliografske jedinice broj: 1153986
BPC 157 therapy and the permanent occlusion of the superior sagittal sinus in rat: vascular recruitment
BPC 157 therapy and the permanent occlusion of the superior sagittal sinus in rat: vascular recruitment // Biomedicines, 9 (2021), 7; 744, 33 doi:10.3390/biomedicines9070744 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1153986 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
BPC 157 therapy and the permanent occlusion of the superior sagittal sinus in rat: vascular recruitment
Autori
Gojković, Slaven ; Krezić, Ivan ; Vraneš, Hrvoje ; Žižek, Helena ; Drmić, Domagoj ; Horvat Pavlov, Katarina ; Petrović, Andreja ; Batelja Vuletić, Lovorka ; Milavić, Marija ; Sikirić, Sunčana ; Stilinović, Irma ; Samara, Mariam ; Knežević, Mario ; Barišić, Ivan ; Sjekavica, Ivica ; Lovrić, Eva ; Škrtić, Anita ; Seiwerth, Sven ; Sikirić, Predrag
Izvornik
Biomedicines (2227-9059) 9
(2021), 7;
744, 33
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
BPC 157 ; superior sagittal sinus ; occlusion ; therapy ; vascular recruitment ; rats
Sažetak
We show the complex syndrome of the occluded superior sagittal sinus, brain swelling and lesions and multiple peripheral organs lesions in rat. Recovery goes centrally and peripherally, with the stable gastric pentadecapeptide BPC 157, which alleviated peripheral vascular occlusion disturbances, rapidly activating alternative bypassing pathways. Assessments were gross recording, venography, ECG, pressure, microscopy, biochemistry. The increased pressure in the superior sagittal sinus, portal and caval hypertension, aortal hypotension, arterial and venous thrombosis, severe brain swelling and lesions (cortex (cerebral, cerebellar), hypothalamus/thalamus, hippocampus), particular veins (azygos, superior mesenteric, inferior caval) dysfunction, heart dysfunction, lung congestion as acute respiratory distress syndrome, kidney disturbances, liver failure, and hemorrhagic lesions in gastrointestinal tract were all assessed. Rats received BPC 157 medication (10 µg/kg, 10 ng/kg) intraperitoneally, intragastrically, or topically to the swollen brain at 1 min ligation-time, or at 15 min, 24 h and 48 h ligation-time. BPC 157 therapy rapidly attenuates the brain swelling, rapidly eliminates the increased pressure in the ligated superior sagittal sinus and the severe portal and caval hypertension and aortal hypotension, and rapidly recruits collateral vessels, centrally ((para)sagittal venous collateral circulation) and peripherally (left superior caval vein azygos vein-inferior caval vein). In conclusion, as shown by all assessments, BPC 157 acts against the permanent occlusion of the superior sagittal sinus and syndrome (i.e., brain, heart, lung, liver, kidney, gastrointestinal lesions, thrombosis), given at 1 min, 15 min, 24 h or 48 h ligation- time. BPC 157 therapy rapidly overwhelms the permanent occlusion of the superior sagittal sinus in ra
Izvorni jezik
Hrvatski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Ivan Domagoj Drmić
(autor)
Mariam Samara
(autor)
Ivan Barišić
(autor)
Mario Knežević
(autor)
Predrag Sikirić
(autor)
Slaven Gojković
(autor)
Anita Škrtić
(autor)
Helena Žižek
(autor)
Sunčana Sikirić
(autor)
Lovorka Batelja Vuletić
(autor)
Sven Seiwerth
(autor)
Ivan Krezić
(autor)
Marija Milavić
(autor)
Ivica Sjekavica
(autor)
Eva Lovrić
(autor)
Andreja Petrović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus